HomeCLDX • NASDAQ
add
Celldex Therapeutics Inc
Previous close
$27.27
Day range
$26.22 - $27.43
Year range
$14.40 - $30.50
Market cap
1.77B USD
Avg Volume
835.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.69M | 6.29% |
Net income | -67.04M | -59.17% |
Net profit margin | — | — |
Earnings per share | -1.01 | -57.81% |
EBITDA | -72.79M | -41.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 583.22M | -22.85% |
Total assets | 648.44M | -21.23% |
Total liabilities | 50.08M | 34.35% |
Total equity | 598.36M | — |
Shares outstanding | 66.45M | — |
Price to book | 3.03 | — |
Return on assets | -27.45% | — |
Return on capital | -29.23% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -67.04M | -59.17% |
Cash from operations | -48.63M | 12.12% |
Cash from investing | 60.85M | 27.41% |
Cash from financing | 774.00K | -37.53% |
Net change in cash | 12.99M | 304.94% |
Free cash flow | -26.39M | 15.57% |
About
Founded
1983
Headquarters
Website
Employees
186
